Subscribe to RSS
Crush cytology: an expeditious diagnostic tool for gastrointestinal tract malignancy
Background and study aims Crush cytology is a simple and rapid method used for diagnosis of central nervous system lesions. We have evaluated the diagnostic accuracy of crush cytology for gastrointestinal tract lesions.
Patients and methods This was a prospective, cross-sectional, single center study, conducted on the patients who had suspected malignant lesions between August 2018 and March 2020. The crush cytologic diagnoses were correlated with histology to determine the diagnostic accuracy.
Results During the period of interest, a total of 451 patients (26.4 % esophagus & GE junction, 16.6 % stomach, 5.9 % ampulla & duodenum, and 50.9 % colorectal) had a suspected malignant lesion on endoscopic examination. Histology confirmed 92.9 % cases as malignant lesions and 7.1 % as nonmalignant. On crush cytology, 84.5 % were positive for malignancy, 8.9 % were negative for malignancy and 6.6 % were reported as suspicious for malignancy. The overall sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of crush cytology were 97.3 %, 90 %, 99.2 %, 72.5 % and 96.9 %, respectively.
Conclusions Crush cytology is a highly sensitive, specific, rapid and cost effective technique to diagnose gastrointestinal malignancies in endoscopically suspected malignant lesions. However, it cannot entirely substitute histopathological examination for definite tumor typing, grading, confirming invasion and in cases in which cytology is suspicious. Crush cytology is an added asset to the histology to maximize diagnostic accuracy and accelerating decision making for the management of lesions.
Received: 10 June 2020
Accepted: 30 December 2020
Article published online:
22 April 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Bray F, Ferlay J, Soerjomatarm I. et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin 2018; 68: 394-424
- 2 Barbeiro S, Libanio D, Castro R. et al. Narrow-band imaging: clinical application in gastrointestinal endoscopy. GE Port J Gastroenterol 2018; 26: 40-53
- 3 Batra M, Handa U, Sachdev A. Comparison of cytohistologic techniques in diagnosis of gastroesophageal malignacy. Acta Cytologica 2006; 52: 77-82
- 4 Kaur S, Sharma R, Kaushal V. et al. Diagnostic accuracy of endoscopic brush cytology in malignancies of upper gastrointestinal tract: A prospective study of 251 patients in North India. J Cancer Res Ther 2016; 12: 681-684
- 5 Yadav KK, Bhatti R, Moorchung N. et al. Is crush cytology of central nervous system lesions relevant in surgical practice today?. J Neurosci Rural Pract 2019; 10: 34-38
- 6 Gv C, Saha D, Yadav R. et al. The Role of crush cytology in the diagnosis of large-intestine lesions with correlation on histopathology. Acta Cytol 2018; 62: 215-222
- 7 Adhya AK, Mohanty R. Utility of touch imprint cytology in the preoperative diagnosis of malignancy in low resource setting. Diagn Cytopathol 2017; 45: 507-512